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ABSTRACT
The human Rad9 checkpointprotein isasubunit of the
heterotrimeric Rad9-Rad1-Hus1 (9-1-1) complex that
plays a role as a damage sensor in the DNA damage
checkpoint response. Rad9 has been found to interact
with several other proteins outside the context of the
9-1-1 complex with no obvious checkpoint functions.
During our studies on the 9-1-1 complex, we found
that Rad9 immunoprecipitates contained a 240 kDa
protein that was identified as carbamoyl phosphate
synthetase/aspartate transcarbamoylase/dihydrooro-
tase (CAD), a multienzymatic protein required for
the de novo synthesis of pyrimidine nucleotides
and cell growth. Further investigations revealed
that only free Rad9, but not Rad9 within the 9-1-1 com-
plex, bound to CAD. The rate-limiting step in de novo
pyrimidine nucleotide synthesis is catalyzed by the
carbamoyl phosphate synthetase II (CPSase) domain
of CAD. We find that Rad9 binds to the CPSase
domain, and, moreover, this binding results in a
2-fold stimulation of the CPSase activity of CAD.
Similar results were also obtained with an N-terminal
Rad9 fragment. These findings suggest that Rad9 may
play a role in ribonucleotide biosynthesis.
INTRODUCTION
The human Rad9, Rad1 and Hus1 proteins make a proliferat-
ing cell nuclear antigen (PCNA)-like heterotrimeric complex
that has a ring structure and is thought to play a PCNA-like
role as a DNA clamp specific for the DNA damage checkpoint
response [reviewed in (1)]. It has been found that the checkpoint-
specific Rad17-replication factor C (RFC) specifically binds to
the Rad9-Rad1-Hus1 (9-1-1) complex and clamps it around a
DNA duplex (2–5). Although the precise mechanism by which
the Rad17-RFC/9-1-1 complex clamp-loader/checkpoint-
clamp senses damage and initiates cell cycle arrest is not
known, significant progress has been made in understanding
the role of this complex.
Investigations into how the 9-1-1 complex may transduce a
signal to downstream proteins in the checkpoint response have
revealed that subunits of the complex, in particular Rad9, inter-
act with a number of other cellular proteins with no obvious role
in cell cycle arrest and have raised the possibility that these
proteins might individually participate in other cellular func-
tionsaswell.Forexample,Rad9has recently beenshowntobind
to the androgen receptor and modulate its activity (6). Rad9 also
binds to the kinases c-Abl (7) and PKCd (8), which in turn
regulate the binding of Rad9 to the antiapoptotic proteins
Bcl-2 and Bcl-xL, suggesting that Rad9 may play a role in the
apoptotic response to genotoxic stress (9).
In the course of our studies on the function of the 9-1-1
complex, we found that when Rad9 was purified by immunoaf-
finity chromatography from extracts of transiently transfected
humancells, thepurifiedRad9preparationcontainedaproteinof
240 kDa as a major contaminant. Mass spectrometric analysis
was used to identify this protein as carbamoyl phosphate syn-
thetase/aspartate transcarbamoylase/dihydroorotase (CAD), a
multienzymatic protein that catalyzes the first three steps in
de novo pyrimidine synthesis (10). The rate-limiting step in
this pyrimidine synthesis pathway iscatalyzed by the carbamoyl
phosphate synthetase II (CPSase) of CAD, which is also the site
of feedback inhibition by uridine nucleotides and activation by
the allosteric ligand phosphoribosyl pyrophosphate (PRPP)
(11). CPSase activity is increased in tumor cells (12,13) and
is regulated by the protein kinase A and mitogen-activated pro-
tein kinase signaling pathways in a growth- and cell-cycle-
dependent manner (14–17). We find that Rad9 binds to the
CPSase domain and that this binding results in a 2-fold stimula-
tion of the CPSase activity of CAD. This is the first documented
report of a protein–protein interaction with CAD regulating its
CPSase activity. We find that CAD interacts with free Rad9, but
not Rad9 within the 9-1-1 checkpoint complex. These findings
suggest that Rad9 may have an additional role to its checkpoint
function in ribonucleotide biosynthesis.
MATERIALS AND METHODS
Materials
Antisera that recognize various antigens were obtained
as follows: rabbit anti-His6 (H-15) and rabbit anti-hRad9
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(M-389) from Santa Cruz Biotechnology (Santa Cruz, CA),
mouse anti-Flag from Sigma (St Louis, MO).
Transfections and immunoprecipitations
Human embryonic kidney 293T cells were grown in
Dulbecco’s modified Eagle’s medium (Gibco BRL) supple-
mented with 10% fetal bovine serum, 100 U of penicillin
and streptomycin per milliliter and were transfected with
pcDNA3-FlaghRad9, pcDNA3-His6FlagCAD, pcDNA3-His6-
FlagCPSII or pcDNA3-HA-hRad9 plasmids using the calcium
phosphate transfection method as described previously (18).
Forty-eight hours after transfection, cells were washed with
phosphate-buffered saline (PBS) and lysed in 20 packed cell
volumes of Lysis Buffer [50 mM Tris–HCl (pH 7.5), 0.3 M
NaCl, 0.5% Nonidet P-40 (NP-40), protease inhibitors (Roche
Molecular Biochemicals)]. After incubating 15 min on ice, the
cell lysate was centrifuged for 30 min at 32 000 g. The
supernatant was incubated with anti-Flag agarose (Sigma)
(20 ml/ml of lysate) for 4 h at 4C. The resin was then washed
twice with Lysis Buffer, twice with Tris-buffered saline (TBS)
[50 mM Tris–HCl (pH 7.5), 150 mM NaCl] and the protein
was eluted for 30 min at 4C with TBS containing 0.2 mg/ml
Flag peptide (Sigma).
Expression and purification of recombinant proteins
Baculoviruses were described previously for expression of
full-length Flag-Rad9 (18), fragments of Rad9 (2,18) and
His6-CAD (19). A monolayer of 2 · 108 High Five insect
cells (Invitrogen) were infected with a multiplicity of infection
of five with either the His6-CAD baculovirus alone or together
with the Flag-Rad9 baculovirus and then harvested after 48 h.
The cells were washed with PBS and lysed in 20 packed cell
volumes of lysis buffer [50 mM Tris–HCl (pH 7.5), 300 mM
NaCl, 15 mM imidazole, 0.5% Nonidet P-40 (NP40) and pro-
tease inhibitors]. After incubating 15 min on ice, the cell lysate
was centrifuged for 30 min at 32 000 g. The supernatant was
incubated with Ni-NTA agarose (Qiagen) (50 ml/ml of lysate)
for 4 h at 4C. The resin was then washed twice with lysis
buffer, twice with elution buffer [50 mM Tris–HCl (pH 7.5),
10% glycerol, 0.3 M NaCl, 2 mM ATP] and then eluted with
two volumes of elution buffer containing 100 mM imidazole.
Typical protein yields of 30 mg were obtained.
Interactions between CAD and Rad9, 9-1-1 and Rad9
fragments
H5 insect cells were co-infected with baculoviruses expressing
either His-CAD alone or together with either Flag-Rad9,
or Flag-Hus1 and His-Rad1, or Flag-Hus1 and His-Rad1
and untagged Rad9, or the five fragments of Rad9 which
were all described previously (2). After lysing the cells in
50 mM Tris–HCl (pH 7.5), 0.3 M NaCl, 0.5% NP40, the
protein was then immunoaffinity purified using anti-Flag agar-
ose. After washing the resin three times in the same buffer, the
protein was eluted with Flag peptide and analyzed by western
blotting.
CPSase activity assay
CPSase activity was measured essentially as described
previously (19). Briefly, all of the reaction components except
the cold and 14C-labeled sodium bicarbonate (the initiation
solution) were added to tubes on ice. These samples then
were placed in a 37C water bath for 10 min before the initia-
tion mix was added to start the reaction. The 250 ml reaction
was allowed to proceed for 30 min at 37C before it was
quenched by the addition of 125 ml of 80% trichloroacetic
acid. The unincorporated 14C was then removed by gently
heating the samples at 85C for 2–3 h. The incorporation of
14C into the acid stable carbamoyl aspartate was then mea-
sured by scintillation counting. The reaction mixture, con-
tained 7.5 ml of the elution buffer previously described,
containing 0.11 mg of CAD, 87 mM Tris–HCl (pH 8.0),
87 mM KCl, 6.5% dimethyl sulfoxide, 2.2% glycerol,
0.87 mM dithiothreitol, 3.1 mM glutamine, 17.4 mM aspartate,
7 mM [14C]NaHCO3 (50 mCi/mmol), 2 mM excess of MgCl2
over the addition of nucleotide and PRPP concentrations and
ATP concentrations (adjusted to ATP contained within the
protein elution buffer) varying from 0.06 to 15 mM.
RESULTS
Copurification of CAD with Rad9
In the course of our studies on the 9-1-1 complex, we found
that when HEK293T cells were transfected with a plasmid
expressing Flag-tagged Rad9 and the protein was purified
with anti-Flag agarose, the preparation contained a major
band of 240 kDa and a minor band of 110 kDa (Figure 1).
The preparation also contained two bands 30 kDa consistent
with the sizes of Rad1 and Hus1, which were at levels stoi-
chiometrically similar to the 240 kDa band when analyzed by
coomassie staining (data not shown). None of these bands
were seen in immunoaffinity-purified extracts from control
cells transfected with the vector alone. Mass spectroscopic
analysis of Rad9-copurifying bands revealed that the
Figure 1. Copurification of CAD with Rad9. An aliquot of 3 · 106 293T cells
were mock treated () or transfected with 6 mg pcDNA3-Flag-hRad9 (+).
Protein was immunoprecipitated using anti-Flag agarose from whole-cell
extracts, and 10% of the protein eluted with Flag peptide was visualized
after SDS–PAGE by silver staining. Mass spectrometric analysis was
performed by the University of North Carolina Mass Spectrometry Core
Facility.
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240 kDa protein is CAD and the 110 kDa protein is the
heat-shock protein hsp110. As heat-shock proteins often
copurify with ectopically expressed proteins, we concentrated
our efforts on characterizing CAD, the major protein that
copurifies with Rad9.
Mapping of CAD and Rad9 domains required for
binding
The human CAD protein catalyzes three separate reactions
with three distinct structural domains, CPSase, aspartate
transcarbamoylase (ATCase) and dihydroorotase (DHOase)
(Figure 2A). Similarly, human Rad9 has an N-terminal
PCNA-like domain and a C-terminal extension which is
heavily phosphorylated and is thought to play a role as an
effector in checkpoint signaling (20–22) (Figure 2B). To
gain insight into the potential physiological significance of
the CAD–Rad9 interaction, we mapped the interacting regions
on both proteins by deletion analysis. In Figure 3, both
full-length CAD and the CPSase domain of CAD were
co-expressed with Rad9 in 293T cells and the CAD and
CPSase immunoprecipitates were immunoblotted for Rad9.
As seen in Figure 3 (right panel), Rad9 bound equally well
to the full-length CAD and to the CPSase domain alone. To
perform reciprocal experiments, insect cells were infected
with baculoviruses expressing CAD together with regions
of Rad9. The Rad9 fragments were immunoprecipitated and
the precipitates were analyzed for CAD by immunoblotting.
As seen in Figure 4, the N-terminal and the middle third, but
not the C-terminal third of Rad9 bound to CAD. The strongest
binding was observed with the N-terminal two-thirds of the
protein. Interestingly, the C-terminal two-thirds bound CAD
with less affinity than the middle third alone, suggesting that
the C-terminal tail may negatively regulate the Rad9–CAD
interaction. While the quantitative aspects of the data
regarding the binding strength has certain limitations, this
data unambiguously show that the PCNA-like domain of
Rad9 binds to CAD whereas the C-terminal domain, which
encompasses the major Rad9 phosphorylation sites and
presumably acts as an effector in checkpoint signaling,
does not.
CAD binds to free Rad9 but not to Rad9 within the
9-1-1 complex
To investigate whether CAD may participate in Rad17-RFC/
9-1-1 complex-mediated signal transduction, we tested the
binding of CAD to the other members of the 9-1-1 complex,
Figure 2. Structural organization of CAD and Rad9. (A) The human CAD
protein has three distinct structural domains performing the three enzymatic
activities, carbamoyl phosphate synthetase (CPS II), aspartate trans-
carbamoylase (ATC) and dihydroorotase (DHO). The CPS II domain is
indicated with gray shading. (B) Human Rad9 has an N-terminal PCNA-like
domain (gray shading) and a heavily phosphorylated C-terminal domain.
Figure 3. Rad9 interacts with the CPSII domain of CAD. An aliquot of 3 · 106
293T cells was transfected with 6 mg of pcDNA3-HA-Rad9 alone (lane 1) or
along with 6 mg of pcDNA3-Flag-CAD (lane 2), or pcDNA3-Flag-CPSII (lane 3).
The proteins were immunoprecipitated with anti-Flag agarose and then
analyzed by western blotting with anti-Rad9 and anti-Flag antibodies as
indicated.
Figure 4. CAD interacts with the PCNA-like domain of Rad9. Insect cells were
infected with His-CAD alone () or together with Flag-tagged fragments of
Rad9 (fragment A contains amino acids 1–130, fragment B contains amino
acids 130–270, fragment C contains amino acids 1–270, fragment D contains
amino acids 260–391 and fragment E contains amino acids 130–391) or with
full-length Rad9 (F). The proteins were immunoprecipitated with anti-Flag
agarose and then analyzed by western blotting with anti-His and anti-Flag
antibodies as indicated.
Nucleic Acids Research, 2004, Vol. 32, No. 15 3
Rad1 and Hus1, as well as to the ternary 9-1-1 complex by
co-infection of insect cells with combinations of baculoviruses
that express these proteins. The tagged 9-1-1 proteins were
immunoprecipitated and the immunoprecipitates were tested
for the other 9-1-1 proteins and for CAD. Figure 5 shows that
Rad9 expressed in insect cells, such as Rad9 expressed in
mammalian cells, binds CAD, but Rad1 and Hus1 do not
(lane 1 versus lane 2). Most significantly, when Rad9 is
co-immunoprecipitated as part of the 9-1-1 complex by using
a Hus1 affinity tag, the immunoprecipitate does not contain
any detectable CAD (lane 3). This was somewhat expected
because Rad9 interacts with Rad1 and Hus1 through its
PCNA-like domain suggesting that this domain is apparently
blocked from binding to CAD within the 9-1-1 complex. These
findings suggested that the Rad9–CAD interaction may have a
role in cellular physiology other than DNA damage checkpoint
signaling.
Modulation of carbamoyl phosphate synthetase activity
Since currently there is no specific assay for Rad9 activity, we
tested for the possible modulation of CAD activity by Rad9
in the following series of experiments. Initially, we found that
the immunoaffinity-purified Rad9–CAD complex exhibited
higher CPSase activity than CAD alone (data not shown).
To further examine the effect of Rad9 on CAD activity, we
examined whether purified proteins could be combined to
recapitulate this regulation. However, when combined in vitro,
the two proteins did not form a stable complex, and we
observed no change in the CPSase activity of CAD (data
not shown). We reasoned that the two proteins may have to
be co-expressed to form a complex, and therefore we
expressed CAD alone and CAD plus Rad9 in insect cells
and purified these recombinant proteins using the His6 tag
on CAD for affinity purification. We obtained the protein
preparations shown in Figure 6. The CAD protein levels
obtained under the two conditions were quite similar, and
the amount of CAD activity was normalized to the amount
of CAD protein in each sample as determined by quantitative
western analysis.
CPSase synthesizes carbamoyl phosphate from ATP, bicar-
bonate and glutamine, and is the first enzymatic step in pyr-
imidine biosynthesis. CPSase is allosterically activated by
PRPP and inhibited by UTP (10). We tested the effect of
Rad9 on CPSase activity in the presence of saturating amounts
of PRPP with varying ATP concentrations. We observed that
the Vmax of CAD was increased 2-fold by Rad9 both in the
presence or absence of PRPP (Figure 7 and Table 1). Kinetic
analysis of CAD/Rad9 complexes revealed that Rad9 did not
significantly change the apparent affinity for ATP (Km) in the
presence or absence of PRPP. Likewise, a fragment of Rad9
lacking the C-terminal phosphorylation sites (fragment C
in Figure 4) had a similar effect on the CPSase activity of
CAD (Figure 7 and Table 1). Thus, it appears that Rad9 reg-
ulates the rate-limiting step of ribonucleotide biosynthesis by
increasing the Vmax of the CPSase activity.
DISCUSSION
Transcriptional induction of ribonucleotide reductase (RNR)
is one of the best-characterized transcriptional response reac-
tions to DNA damage and has been observed in organisms
ranging from Escherichia coli to humans (23). The upregula-
tion of RNR activity by either transcriptional or post-transcrip-
tional means increases the dNTP pools, and it has been shown
that an increase in dNTP levels following DNA damage
increases cellular survival in budding yeast (24). Since
rNTP pools are typically 100-fold higher than the dNTP
pools, it has generally been assumed that changes in rNTP
levels would not affect the dNTP pool and hence the survival
Figure 5. CAD binds to free Rad9 but not to Rad9 within the 9-1-1 complex.
Insect cells were co-infected with His-CAD together with Flag-Rad9 (lane 1), or
Flag-Hus1 and His-Rad1 (lane 2), or Flag-Hus1, His-Rad1 and untagged-Rad9
(lane 3). The proteins were immunoprecipitated with anti-Flag agarose and then
analyzed by western blotting with anti-His, anti-Rad9 and anti-Flag antibodies
as indicated.
Figure 6. Purification of CAD with and without Rad9. Insect cells were infected
with His-CAD alone or together with Flag-Rad9. The proteins were affinity
purified with Ni-agarose and then analyzed by Coomassie staining (left panel)
and western blotting (right panels). The arrow indicates the position of CAD.
Aliquots of 2.5, 5, 10 ml from each sample was loaded which correlates to 50,
100, 200 ng of CAD and 25, 50, 100 ng of Rad9 when quantitated using protein
standards in the same gel.
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and mutation rate. This assumption, however, has not been
experimentally tested. Furthermore, RNA synthesis which
would be affected by rNTP levels might contribute to cellular
recovery from genotoxic stress. Such an outcome of a Rad9–
CAD interaction would place this interaction within the
general DNA damage response network. However, it is also
plausible that the Rad9–CAD interaction is operational under
physiological conditions to maintain cellular homeostasis and
that this function is not related to the checkpoint function of
Rad9 which occurs within the context of the 9-1-1 complex.
Indeed, Rad9 has been found to associate with a number of
proteins with diverse functions some of which are not related
the DNA damage checkpoint response. Additionally, de novo
pyrimidine biosynthesis is not only important in dividing cells
for the production of new nucleic acids, but also for UDP–
sugars and CDP–lipids, which are used for diverse cellular
functions [reviewed in (17)]. Therefore, the Rad9-induced
increase in CAD activity could be important in many different
areas of cell physiology.
We currently do not know the cellular location of the CAD–
Rad9 interaction. While CAD is mainly cytoplasmic, some
studies have provided evidence for a fraction of CAD being
in the nucleus (16,25,26). Under normal cellular conditions,
Rad9 is part of the nuclear 9-1-1 complex (27,28). However,
Rad9 does appear to have an independent cytoplasmic func-
tion during apoptosis. It has been demonstrated that during
apoptosis Rad9 is cleaved by caspase-3 and the N-terminal
portion of Rad9 translocates to the cytosol where it interacts
with Bcl-xL (29). Since CAD does not associate with the 9-1-1
complex (Figure 5), and all detectable nuclear Rad9 is in this
complex (27), it is likely that the CAD–Rad9 interaction takes
place in the cytoplasm. We could not detect the Rad9–CAD
interaction by immunoprecipitating endogenous Rad9 pre-
sumably because the interaction is weak relative to the 9-1-1
interaction and therefore is detectable only when Rad9 is
overproduced.
CAD is a unique biosynthetic enzyme with three distinct
enzymatic activities. The CPSase enzyme domain catalyzes
Figure 7. Rad9 increases the CPSase Vmax. CPSase activity was measured from purified CAD (square) expressed alone or co-expressed with full-length Rad9
(triangle) or Rad9 with a C-terminal deletion (upside-down triangle) in the absence (A) or presence (B) of 2 mM PRPP with varying concentrations of ATP. The CAD
and CAD/Rad9 data represent pooled results from five separate experiments, while the data from the CAD/Rad9 fragment C represent pooled data from two separate
experiments. The curves were generated using GraphPad Prism version 4.01 for Windows (GraphPad Software, San Diego, CA, www.graphpad.com) by performing
nonlinear regression analysis to fit the raw data to the equation Y = Vmax * Xh/(Kh + Xh) where h is the Hill coefficient (set to 2) and K is the apparent Km.
Table 1. Kinetic parameters of wild-type CAD and CAD co-expressed with
Rad9 and Rad9 fragment C
Ligand Km Vmax
CAD None 4.5 – 0.43 7.3 – 0.38
PRPP 0.4 – 0.05 13.4 – 0.43
CAD/Rad9 None 4.6 – 0.40 17.8 – 0.86
PRPP 0.5 – 0.07 26.8 – 0.99
CAD/Rad9 fragment C None 3.8 – 0.40 14.3 – 0.65
PRPP 0.5 – 0.10 27.3 – 1.67
The kinetic parameters of the CPSase data from CAD and CAD/Rad9 represent
pooled data from five separate experiments, while the data from the CAD/Rad9
fragment represents pooled data from two separate experiments. Km (mM ATP)
is the apparent affinity for ATP, and Vmax (pmol min
1) is the maximum CPSase
velocity measured as a function of ATP concentration. These data are the
numerical results from the graphs in Figure 7.
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the formation of carbamoyl phosphate from glutamine, bicar-
bonate and two molecules of ATP. The ATCase region cat-
alyzes the synthesis of carbamoyl aspartate from aspartate and
carbamoyl phosphate. Finally, the formation of dihydroorotate
is catalyzed by the DHOase domain (11). The assay used in
these studies to measure CPSase activity is a coupled enzyme
assay which measures the incorporation of [14C] into the acid-
stable chemical carbamoyl aspartate, which, as mentioned
above, is catalyzed by the enzymatic activities of both the
CPS II and ATC domains. However, since the CPSase activity
is rate limiting (10,30), the observed changes in enzymatic
activity are most likely due to changes in the CPSase activity
of CAD.
The CPSase activity of CAD is highly regulated. As men-
tioned previously, it is allosterically activated by PRPP and
inhibited by the product of pyrimidine-nucleotide synthesis,
uridine 50-triphosphate (UTP). Moreover, phosphorylation can
affect the allosteric regulation by PRPP and UTP (14,31). An
additional level of regulation of CPSase activity is by protein
degradation induced by caspase-3 (19). The findings reported
in this study add a previously unknown mode of CPSase
activity regulation. Our data reveal the first documented report
that a protein–protein interaction with CAD can regulate
CPSase activity. Although allosteric regulators (i.e. PRPP and
UTP) decrease the Km for a CPSase substrate (ATP), our data
suggests that Rad9 increases the Vmax of CPSase rather than
changing the Km for ATP. Rad9 binding was also observed to
increase the maximum velocity of CPSase activity in the
presence of PRPP, but did not affect the percentage activation
by PRPP. We investigated the affect of Rad9 on UTP-induced
inhibition of CPSase activity. Rad9 did not significantly
decrease the inhibitory action of UTP, but this result varied
between CAD protein preparations preventing us from making
a conclusion from this data (data not shown).
The mechanism by which Rad9 increases CPSase activity is
not known. Rad9 binding could increase the affinity of other
CPS II substrates such as glutamine or bicarbonate. Another
plausible hypothesis is that Rad9 increases the glutaminase
activity of CPS II, thereby increasing the overall Vmax without
affecting the affinity for ATP. However, this appears unlikely
since experiments using ammonia as the nitrogen donor,
thereby bypassing the need for the glutaminase activity,
have shown that Rad9 still induced a 2-fold increase in CPSase
activity (data not shown). Alternatively, Rad9 binding may
induce a conformational shift that affects the oligomeric (acti-
vated) form of the enzyme. Active CAD has been shown to be
a hexamer (31,32), and Rad9 may increase CAD activity by
increasing the amount of enzyme in the hexameric form. Dis-
sociation of CAD to monomers did not affect the CPSase
activity, but significantly reduced the Vmax of ATCase (32).
It is therefore possible that Rad9 could be increasing CAD
activity by stabilizing the oligomeric form of this enzyme and
thereby increasing the Vmax of ATCase. However, this seems
unlikely since the CPSase activity of CAD is the rate-limiting
step (30), and an increase in the ATCase rate would not
be expected to increase the overall rate of our coupled
enzyme reaction.
In summary, we find that the checkpoint protein Rad9
specifically interacts with the CPSase domain of CAD and
increases its Vmax by at least a factor of two. The high spe-
cificity of the Rad9–CAD interaction strongly suggests that it
is of significance to normal cellular homeostasis. Further work
is needed to determine the potential role of this interaction in
regulating DNA damage checkpoints, ribonucleotide pools or
RNA and DNA synthesis.
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